PDL BioPharma Inc (NASDAQ:PDLI)

6.66
Delayed Data
As of May 22
 +0.02 / +0.30%
Today’s Change
6.38
Today|||52-Week Range
10.26
-13.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line92.1M102.2M55.1M84.5M
 
 
 
 
 
Total Other Cash Flow-40.3M-23.3M33.7M-6.8M
 
 
 
 
 
Funds From Operations38.3M75.0M75.5M81.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-16.1M-2.1M6.4M9.2M
 
 
 
 
 
Net Cash Flow - Operating Activities54.4M77.1M69.0M71.8M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-1.8M0.00
 
 
Decrease In Investments0.000.003.5M0.00
 
 
Capital Expenditures-39.0K-10.0K0.000.00
 
 
 
Other Investing - Uses-215.0M0.00-15.0M0.00
 
 
 
Other Investing - Sources49.5M32.3M89.5M938.0K
 
 
 
 
 
Net Cash Flow Investing-131.1M32.3M10.7M938.0K
 
 
 
 
 
 
FinancingShort Term Borrowings-18.8M-18.8M-18.8M100.0M
 
 
 
 
 
Long Term Borrowings0.00537.0K-538.0K-607.0K
 
 
 
 
Long Term Debt Reduction0.000.00-26.3M-22.3M
 
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed0.000.00-31.0M0.00
 
 
Common Dividends----------
Cash Dividends Paid - Total-24.0M-24.0M-24.4M-24.5M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.00-31.0M0.00
 
 
Net Cash Flow - Financing-42.8M-42.3M-70.0M52.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash-119.5M67.1M9.8M125.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account